Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer

NCT00350025 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Urologic Neoplasm

Interventions

DRUG: Cetuximab
DRUG: Paclitaxel

Sponsor

Fox Chase Cancer Center

Collaborators

[object Object]